<p>Novem Group 在第四季度购买了 IDEXX Laboratories, Inc.（纳斯达克代码：IDXX - 免费报告）的新头寸，根据其最近向证券交易委员会（SEC）提交的 13F 文件。这家机构投资者购买了 2,065 股该公司的股票，价值约为 854,000 美元。</p>
<p>获取 <strong>IDEXX Laboratories</strong> 警报：</p>
<ul>
<li>看涨还是看跌？评估动物健康护理股票</li>
</ul>
<p>其他一些对冲基金最近也对该股票的头寸进行了调整。Hurley Capital LLC 在第四季度购买了价值 29,000 美元的 IDEXX Laboratories 新股份。Rialto Wealth Management LLC 在第四季度购买了价值 30,000 美元的 IDEXX Laboratories 新头寸。Colonial Trust Co SC 在第四季度将其在 IDEXX Laboratories 的持股增加了 84.8%。Colonial Trust Co SC 现在拥有 85 股该公司的股票，价值 35,000 美元，此前在上个季度又收购了 39 股。Kestra Investment Management LLC 在第四季度购买了价值约 38,000 美元的 IDEXX Laboratories 新股份。最后，Itau Unibanco Holding S.A.在第四季度将其在 IDEXX Laboratories 的股份增加了 540.0%。Itau Unibanco Holding S.A.现在拥有 96 股该公司的股票，价值 40,000 美元，此前在此期间又收购了 81 股。目前 87.84% 的股票由机构投资者持有。</p>
<h2>分析师升级和降级</h2>
<p>几位股票研究分析师最近对 IDXX 股票发表了看法。摩根士丹利将 IDEXX Laboratories 的股票目标价从 548.00 美元上调至 558.00 美元，并在 5 月 5 日的研究报告中给予该股票 “超配” 评级。巴克莱将 IDEXX Laboratories 的目标价从 481.00 美元上调至 520.00 美元，并在 2 月 4 日的报告中给予该股票 “超配” 评级。Piper Sandler 将 IDEXX Laboratories 的目标价从 435.00 美元上调至 510.00 美元，并在 2 月 10 日的研究报告中给予该股票 “中性” 评级。美国银行将 IDEXX Laboratories 的目标价从 475.00 美元上调至 535.00 美元，并在 2 月 4 日的研究报告中给予该股票 “中性” 评级。最后，Stifel Nicolaus 将 IDEXX Laboratories 的目标价从 460.00 美元上调至 510.00 美元，并在周一的研究报告中给予该公司 “持有” 评级。三位股票研究分析师对该股票给予了 “持有” 评级，六位给予了 “买入” 评级，一位给予了 “强烈买入” 评级。根据 MarketBeat 的数据，该公司目前的共识评级为 “适度买入”，共识目标价为 536.00 美元。</p>
<p><strong>查看我们对 IDXX 的最新分析</strong></p>
<h2>IDEXX Laboratories 价格表现</h2>
<p>IDXX 股票在周四开盘价为 500.87 美元。IDEXX Laboratories, Inc.的 52 周低点为 356.14 美元，52 周高点为 530.60 美元。该公司的债务与股本比率为 0.28，速动比率为 0.95，流动比率为 1.31。该公司的市值为 402.8 亿美元，市盈率为 46.94，PEG 比率为 3.41，贝塔值为 1.52。该股票的 50 日简单移动平均线为 437.40 美元，200 日简单移动平均线为 433.24 美元。</p>
<p>IDEXX Laboratories（纳斯达克代码：IDXX - 获取免费报告）最近于 5 月 1 日发布了其财报。该公司报告本季度每股收益为 2.96 美元，超出市场共识预期的 2.93 美元，超出 0.03 美元。该公司本季度的收入为 9.9843 亿美元，而市场共识预期为 9.9825 亿美元。IDEXX Laboratories 的净利润率为 22.78%，股本回报率为 55.82%。与去年同期相比，IDEXX Laboratories 的收入增长了 3.6%。在去年同期，该公司每股收益为 2.71 美元。整体来看，股票分析师预测 IDEXX Laboratories, Inc.在当前财年将发布 11.93 美元的每股收益。</p>
<h2>关于 IDEXX Laboratories</h2>
<p>（免费报告）</p>
<p>IDEXX Laboratories, Inc.主要为伴侣动物兽医、牲畜和家禽、乳制品以及水质检测市场开发、制造和分销产品，业务遍及非洲、亚太地区、加拿大、欧洲、拉丁美洲及国际市场。该公司通过三个部门运营：伴侣动物组；水质产品；以及牲畜、家禽和乳制品。</p>
<h2>精选故事</h2>
<ul>
<li>我们更看好的五只股票超过 IDEXX Laboratories</li>
<li>FTSE 100 指数是什么？</li>
<li>300 亿美元的人工智能机会：它会推动 Meta 的下一次激增吗？</li>
<li>如何计算投资回报率（ROI）</li>
<li>随着欧盟反垄断案件接近解决，微软可能会反弹</li>
<li>你应该将这些沃伦·巴菲特的股票加入你的投资组合吗？</li>
<li>英特尔重新聚焦：NEX 出售和铸造转型标志着新时代的开始</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SURYWA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SURYWA"/></p>
<p><em>此即时新闻警报由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对本故事有任何问题或意见，请发送电子邮件至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 IDEXX Laboratories 吗？</h2>
<p>在你考虑 IDEXX Laboratories 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐购买，以便在更广泛的市场注意到之前……而 IDEXX Laboratories 并不在名单上。</p>
<p>虽然 IDEXX Laboratories 目前在分析师中获得 “适度买入” 评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

IDEXX实验室

<p>Novem Group 在最近的 SEC 文件中报告，已在 IDEXX Laboratories, Inc.（纳斯达克代码：IDXX）投资 854,000 美元，购买了 2,065 股。其他对冲基金也增加了在 IDEXX 的持股。分析师们提高了该股票的目标价，普遍评级为 “适度买入”，目标价为 536 美元。IDEXX 报告每股收益为 2.96 美元，超出预期，上一季度的收入为 9.9843 亿美元，同比增长 3.6%</p>

<p>Novem Group purchased a new position in IDEXX Laboratories, Inc. (NASDAQ:IDXX - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 2,065 shares of the company's stock, valued at approximately $854,000.</p>
<div class="lb-trans"><p>Novem Group 在第四季度购买了 IDEXX Laboratories, Inc.（纳斯达克代码：IDXX - 免费报告）的新头寸，根据其最近向证券交易委员会（SEC）提交的 13F 文件。这家机构投资者购买了 2,065 股该公司的股票，价值约为 854,000 美元。</p>
</div><p>Get <strong>IDEXX Laboratories</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>IDEXX Laboratories</strong> 警报：</p>
</div><ul>
<li>Bullish or Bearish? Vetting Animal Health Care Stocks</li>
</ul>
<div class="lb-trans"><ul>
<li>看涨还是看跌？评估动物健康护理股票</li>
</ul>
</div><p>A number of other hedge funds have also recently made changes to their positions in the stock. Hurley Capital LLC bought a new stake in IDEXX Laboratories during the 4th quarter valued at $29,000. Rialto Wealth Management LLC purchased a new position in shares of IDEXX Laboratories during the fourth quarter valued at $30,000. Colonial Trust Co SC raised its holdings in shares of IDEXX Laboratories by 84.8% in the fourth quarter. Colonial Trust Co SC now owns 85 shares of the company's stock valued at $35,000 after acquiring an additional 39 shares in the last quarter. Kestra Investment Management LLC bought a new stake in shares of IDEXX Laboratories in the fourth quarter valued at about $38,000. Finally, Itau Unibanco Holding S.A. lifted its stake in IDEXX Laboratories by 540.0% in the fourth quarter. Itau Unibanco Holding S.A. now owns 96 shares of the company's stock worth $40,000 after acquiring an additional 81 shares during the period. 87.84% of the stock is currently owned by institutional investors.</p>
<div class="lb-trans"><p>其他一些对冲基金最近也对该股票的头寸进行了调整。Hurley Capital LLC 在第四季度购买了价值 29,000 美元的 IDEXX Laboratories 新股份。Rialto Wealth Management LLC 在第四季度购买了价值 30,000 美元的 IDEXX Laboratories 新头寸。Colonial Trust Co SC 在第四季度将其在 IDEXX Laboratories 的持股增加了 84.8%。Colonial Trust Co SC 现在拥有 85 股该公司的股票，价值 35,000 美元，此前在上个季度又收购了 39 股。Kestra Investment Management LLC 在第四季度购买了价值约 38,000 美元的 IDEXX Laboratories 新股份。最后，Itau Unibanco Holding S.A.在第四季度将其在 IDEXX Laboratories 的股份增加了 540.0%。Itau Unibanco Holding S.A.现在拥有 96 股该公司的股票，价值 40,000 美元，此前在此期间又收购了 81 股。目前 87.84% 的股票由机构投资者持有。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析师升级和降级</h2>
</div><p>Several equities research analysts have recently weighed in on IDXX shares. Morgan Stanley upped their price target on shares of IDEXX Laboratories from $548.00 to $558.00 and gave the stock an &#34;overweight&#34; rating in a research report on Monday, May 5th. Barclays upped their target price on IDEXX Laboratories from $481.00 to $520.00 and gave the stock an &#34;overweight&#34; rating in a report on Tuesday, February 4th. Piper Sandler boosted their price target on IDEXX Laboratories from $435.00 to $510.00 and gave the stock a &#34;neutral&#34; rating in a research report on Monday, February 10th. Bank of America upped their price objective on IDEXX Laboratories from $475.00 to $535.00 and gave the stock a &#34;neutral&#34; rating in a research note on Tuesday, February 4th. Finally, Stifel Nicolaus lifted their target price on IDEXX Laboratories from $460.00 to $510.00 and gave the company a &#34;hold&#34; rating in a research note on Monday. Three equities research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of &#34;Moderate Buy&#34; and a consensus price target of $536.00.</p>
<div class="lb-trans"><p>几位股票研究分析师最近对 IDXX 股票发表了看法。摩根士丹利将 IDEXX Laboratories 的股票目标价从 548.00 美元上调至 558.00 美元，并在 5 月 5 日的研究报告中给予该股票 “超配” 评级。巴克莱将 IDEXX Laboratories 的目标价从 481.00 美元上调至 520.00 美元，并在 2 月 4 日的报告中给予该股票 “超配” 评级。Piper Sandler 将 IDEXX Laboratories 的目标价从 435.00 美元上调至 510.00 美元，并在 2 月 10 日的研究报告中给予该股票 “中性” 评级。美国银行将 IDEXX Laboratories 的目标价从 475.00 美元上调至 535.00 美元，并在 2 月 4 日的研究报告中给予该股票 “中性” 评级。最后，Stifel Nicolaus 将 IDEXX Laboratories 的目标价从 460.00 美元上调至 510.00 美元，并在周一的研究报告中给予该公司 “持有” 评级。三位股票研究分析师对该股票给予了 “持有” 评级，六位给予了 “买入” 评级，一位给予了 “强烈买入” 评级。根据 MarketBeat 的数据，该公司目前的共识评级为 “适度买入”，共识目标价为 536.00 美元。</p>
</div><p><strong>View Our Latest Analysis on IDXX</strong></p>
<div class="lb-trans"><p><strong>查看我们对 IDXX 的最新分析</strong></p>
</div><h2>IDEXX Laboratories Price Performance</h2>
<div class="lb-trans"><h2>IDEXX Laboratories 价格表现</h2>
</div><p>Shares of IDXX stock opened at $500.87 on Thursday. IDEXX Laboratories, Inc. has a fifty-two week low of $356.14 and a fifty-two week high of $530.60. The company has a debt-to-equity ratio of 0.28, a quick ratio of 0.95 and a current ratio of 1.31. The firm has a market capitalization of $40.28 billion, a price-to-earnings ratio of 46.94, a PEG ratio of 3.41 and a beta of 1.52. The stock's 50-day simple moving average is $437.40 and its 200-day simple moving average is $433.24.</p>
<div class="lb-trans"><p>IDXX 股票在周四开盘价为 500.87 美元。IDEXX Laboratories, Inc.的 52 周低点为 356.14 美元，52 周高点为 530.60 美元。该公司的债务与股本比率为 0.28，速动比率为 0.95，流动比率为 1.31。该公司的市值为 402.8 亿美元，市盈率为 46.94，PEG 比率为 3.41，贝塔值为 1.52。该股票的 50 日简单移动平均线为 437.40 美元，200 日简单移动平均线为 433.24 美元。</p>
</div><p>IDEXX Laboratories (NASDAQ:IDXX - Get Free Report) last released its earnings results on Thursday, May 1st. The company reported $2.96 earnings per share for the quarter, topping the consensus estimate of $2.93 by $0.03. The company had revenue of $998.43 million for the quarter, compared to the consensus estimate of $998.25 million. IDEXX Laboratories had a net margin of 22.78% and a return on equity of 55.82%. IDEXX Laboratories's revenue was up 3.6% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $2.71 EPS. As a group, equities analysts forecast that IDEXX Laboratories, Inc. will post 11.93 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>IDEXX Laboratories（纳斯达克代码：IDXX - 获取免费报告）最近于 5 月 1 日发布了其财报。该公司报告本季度每股收益为 2.96 美元，超出市场共识预期的 2.93 美元，超出 0.03 美元。该公司本季度的收入为 9.9843 亿美元，而市场共识预期为 9.9825 亿美元。IDEXX Laboratories 的净利润率为 22.78%，股本回报率为 55.82%。与去年同期相比，IDEXX Laboratories 的收入增长了 3.6%。在去年同期，该公司每股收益为 2.71 美元。整体来看，股票分析师预测 IDEXX Laboratories, Inc.在当前财年将发布 11.93 美元的每股收益。</p>
</div><h2>About IDEXX Laboratories</h2>
<div class="lb-trans"><h2>关于 IDEXX Laboratories</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>IDEXX Laboratories, Inc develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy.</p>
<div class="lb-trans"><p>IDEXX Laboratories, Inc.主要为伴侣动物兽医、牲畜和家禽、乳制品以及水质检测市场开发、制造和分销产品，业务遍及非洲、亚太地区、加拿大、欧洲、拉丁美洲及国际市场。该公司通过三个部门运营：伴侣动物组；水质产品；以及牲畜、家禽和乳制品。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精选故事</h2>
</div><ul>
<li>Five stocks we like better than IDEXX Laboratories</li>
<li>What is the FTSE 100 index?</li>
<li>$30B AI Opportunity: Will It Power Meta’s Next Surge?</li>
<li>How to Calculate Return on Investment (ROI)</li>
<li>Microsoft Could Rally as EU Antitrust Case Nears Resolution</li>
<li>Should You Add These Warren Buffett Stocks to Your Portfolio?</li>
<li>Intel Refocuses: NEX Sale and Foundry Pivot Signal New Era</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票超过 IDEXX Laboratories</li>
<li>FTSE 100 指数是什么？</li>
<li>300 亿美元的人工智能机会：它会推动 Meta 的下一次激增吗？</li>
<li>如何计算投资回报率（ROI）</li>
<li>随着欧盟反垄断案件接近解决，微软可能会反弹</li>
<li>你应该将这些沃伦·巴菲特的股票加入你的投资组合吗？</li>
<li>英特尔重新聚焦：NEX 出售和铸造转型标志着新时代的开始</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SURYWA" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NASDAQ&amp;Symbol=IDXX"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻警报由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对本故事有任何问题或意见，请发送电子邮件至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in IDEXX Laboratories Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 IDEXX Laboratories 吗？</h2>
</div><p>Before you consider IDEXX Laboratories, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑 IDEXX Laboratories 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and IDEXX Laboratories wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐购买，以便在更广泛的市场注意到之前……而 IDEXX Laboratories 并不在名单上。</p>
</div><p>While IDEXX Laboratories currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 IDEXX Laboratories 目前在分析师中获得 “适度买入” 评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Novem Group 向 IDEXX 实验室公司（NASDAQ:IDXX）投资了 854,000 美元